You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《美股業績》阿斯利康(AZN.US)季度純利跌16%遜預期 上調全年收入及利潤指引
阿思達克 11-09 16:23
英國-瑞典合資藥業巨擘阿斯利康(AstraZeneca)(AZN.US)公布截至9月底止第三季業績,總收入114.92億美元,按年升5%,以固定匯率計則升6%,與市場預期的115.5億美元相若;倘撇除新冠藥品,第三季收入按年升12%,以固定匯率計則升13%。 受累期內稅務開支2.74億美元入賬,季度純利13.7億美元,按年跌16.1%,低於市場預期的15.8億美元;每股季度盈利89美仙,每股核心純利1.73美元,高於市場預期的1.69美元。 阿斯利康上調全年度核心純利及收入指引,以固定匯率計,料全年度收入錄中單位數增長,原先料低至中單位數增長;料全年度核心純利錄低雙位數至20%低端增長,原先料高單位數至低雙位數增長。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account